Isolate Data
| Patient | Isolate | Region | Year | Species | Subtype | Source | Clone Method |
| 260Pt6 | 260Pt6W8C | U.S. | 1996 | HIV1 | B | PBMC | None |
Treatment History
| Order | Regimen | Weeks |
| 1 | AZT | NA |
| 2 | DLV | 8 |
RT Sequence
| NRTIMajorDRMs | NRTIMinorDRMs | NNRTIMajorDRMs | NNRTIMinorDRMs | Polys | UnusualMuts |
| T215CY | K103N, Y181C | S68G, R83K, T139M, S162C, T200TI |
| >260Pt6W8C| codons 30-244 KIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDGTKWRKLVDFRELNKKTQDFWE VQLGIPHPAGLKKNKSVTVLDVGDAYFSVPLDKDFRKYTAFTIPSINNEMPGIRYQYNVL PQGWKGSPAIFQCSMTKILEPFRKQNPDIVICQYMDDLYVGSDLEIGQHRIKIEELRQHL LRWGFYTPDKKHQKEPPFLWMGYELHPDKWTVQPI |
References
| Author | Title | Citation |
| Demeter, LM | Delavirdine susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type I isolates from patients in a phase I/II trial of delavirdine monotherapy (ACTG 260). | AAC, 2000 |
| Rhee, SY | HIV-1 Protease and Reverse Transcriptase Mutations: Correlations with Antiretroviral Therapy in Subtype B Isolates and Implications for Drug-Resistance Surveillance. | J Infect Dis, 2005 |